Michael Rosen MD MSCI

PubMed

• Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery.
  Debarun Patra, Ibrahim M Sayed, Souhrid Mukherjee, Honit Piplani, Aida Habtezion
  Advanced Science. 2026-04-01
• Multi-omics reveal vitamin D regulation of immune-gut microbiome interactions and tolerogenic pathways in inflammatory bowel disease.
  John Gubatan, Raoul S Sojwal, Jiayu Ye, Theresa L Boye, Jacqueline N Hoang
  Cell Reports. Medicine. 2026-03-26
• Integrating intestinal ultrasound into routine clinical care improves prediction of biochemical disease activity in pediatric inflammatory bowel disease.
  Perseus V Patel, Destiny J Zuniga, Alka Goyal, Rachel Bensen, Dorsey Bass
  Inflammatory Bowel Diseases. 2026-02-06

Journal Articles

• Mucosal type 2 and type 17 gene expression distinguishes ulcerative colitis from colon-only Crohn�s disease in treatment-na�ve pediatric patients  
  Rosen MJ, Karns R, Vallance JE, Bezold R, Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams JS, Baker SS, Kellermayer R, Noe J, Griffiths AM, Rosh JR, C..., Gastroenterology, 1/1/2017
•  
  Liu Z, Kong F, Vallance JE, Harmel-Laws E, Amarachintha S, Steinbrecher KA, Rosen MJ, Bhattacharyya S., Physiological Reports., 1/1/2017
• Microbiota-sensitive epigenetic signature predicts inflammation in Crohn�s disease  
  Kelly D, Kotliar M, Woo V, Jagannathan S, Whitt J, Moncivaiz J, Aronow BJ, Dubinsky MC, Hyams JS, Markowitz JF, Baldassano RN, Stephens MC, Walters TD, Kugathasan S, H..., JCI Insight, 1/1/2017

Abstracts/Posters

• The treatment na�ve rectal transcriptome identifies pathways mediating clinical and endoscopic severity and response to initial therapy in pediatric ulcerative colitis.
  Haberman Y, Karns R, Dexheimer PJ, Bauman LE, Collins MH, Rosen MJ, et al., AGA Annual Scientific Meeting at DDW, Washington, DC, 1/1/2018
• Effect of an Anti-TNF Therapeutic Drug Monitoring Quality Improvement Program on Inflammatory Bowel Disease Patient Outcomes at a Large Academic Pediatric Gastroentero...
  Mulgund AA, Bauman L, Chona DL, Sharma P, Su W, Fei L, Denson LA, Minar P, Dykes DM, Rosen MJ., World Congress of Gastroenterology at ACG, NASPGHAN Annual Scientific Meeting, 1/1/2017
• IL-33 indirectly induces goblet cell hyperplasia in the murine intestine through IL-13 production by type 2 innate lymphoid cells.
  Waddell AP, Vallance JE, Rosen MJ., AGA Abstracts published in Gastroenterology, 1/1/2017

Lectures

• Cases from the Wards 
  Children�s Hospital Boston - 1/1/2005
• Progress and Challenges in Pediatric Inflammatory Bowel Disease Research 
  1/17/2012
• Type 2 Inflammation in Pediatric Inflammatory Bowel Disease 
  Children�s Hospital of Fudan University - 1/9./2016

Other

• Outcome following infliximab therapy for pediatric patients hospitalized with refractory colitis-predominant inflammatory bowel disease. 
  Falaiye TO, Mitchell KR, Lu Z, Saville BR, Horst SN, Moulton DE, Schwartz DA, Wilson KT, Rosen MJ., Biologic Treatment of Pediatric Inflammatory Bowel Disease: A Decade of JPGN Contributions
  1/1/2014